Research funding: None declared
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
Competing interests: Authors state no conflict of interest.
References
1. Aboussouan, LS, Stroller, JK. Detection of alpha-1 antitrypsin deficiency: a review. Respir Med 2009;103:335–41. https://doi.org/10.1016/j.rmed.2008.10.006.Search in Google Scholar PubMed
2. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2003;168:818–900. https://doi.org/10.1164/rccm.168.7.818.Search in Google Scholar PubMed
3. Laurell, CB, Eriksson, S. The electrophoretic alpha-1-globulin pattern of serum in alpha-1-antitrypsin deficiency. Scand J Clin Lab Invest 1963;15:132–40. https://doi.org/10.3109/00365516309051324.Search in Google Scholar
4. Donato, LJ, Jenkins, SM, Smith, C, Katzmann, JA, Snyder, MR. Reference and interpretive ranges for α 1-antitrypsin quantitation by phenotype in adult and pediatric populations. Am J Clin Pathol 2012;138 3:398–405. https://doi.org/10.1309/ajcpmeejk32acyfp.Search in Google Scholar PubMed
5. Franciosi, AN, Carroll, TP, McElvaney, NG. Pitfalls and caveats in α1-antitrypsin deficiency testing: a guide for clinicians. Lancet Respir Med 2019;7:1059. https://doi.org/10.1016/s2213-2600(19)30141-9.Search in Google Scholar
6. McKeeman, GC, Hall, SL, Freedman, DB. Reflex and reflective testing practice in Clinical Biochemistry in the United Kingdom – a national survey. Ann Clin Biochem 2020;57:77–87. https://doi.org/10.1177/0004563219888541.Search in Google Scholar PubMed
7. Franciosi, AN, Hobbs, BD, McElvaney, OJ, Molloy, K, Hersh, C, Clarke, L, et al.. Clarifying the risk of lung disease in SZ alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2020;202:73. https://doi.org/10.1164/rccm.202002-0262oc.Search in Google Scholar
8. Molloy, K, Hersh, CP, Morris, VB, Carroll, TP, O’Connor, CA, Lasky-Su, JA, et al.. Clarification of the risk of chronic obstructive pulmonary disease in α1-antitrypsin deficiency PiMZ heterozygotes. Am J Respir Crit Care Med 2014;189:419–27. https://doi.org/10.1164/rccm.201311-1984oc.Search in Google Scholar PubMed PubMed Central
© 2021 Walter de Gruyter GmbH, Berlin/Boston